A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer's disease, drugmaker Novo Nordisk announced on Nov. 24.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback